Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease

Journal of Hepatology

Volumn 31, Issue 1, 1999, Pages 84-90

  Ormarsdóttir, Sif ^a   Ljunggren, Östen ^a   Mallmin, Hans ^a   Brahm, Helena ^a   Lööf, Lars ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Body mass index; Cholestasis; Chronic liver disease; Corticosteroids; One mineral density; Osteoporosis

Indexed keywords

CALCIFEDIOL; CALCIUM; CORTICOSTEROID; PARATHYROID HORMONE;

ARTICLE; BODY MASS; BONE DENSITY; BONE MINERAL; CALCIUM BLOOD LEVEL; CHOLESTASIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RADIODIAGNOSIS; RISK ASSESSMENT; RISK FACTOR; SENESCENCE; SEX DIFFERENCE; VITAMIN BLOOD LEVEL;

EID: 0344867878     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80167-6     Document Type: Article

References (46)

1. Sherlock S, Dooley J. Diseases of the Liver and Biliary System, 9th edn. 1993;Blackwell Scientific Publications, Oxford.
2. Diamond TH. Metabolic bone disease in primary biliary cirrhosis. Hepatology. 5:1990;66-81.
3. Porayko MK, Wiesner RH, Hay JE, Krom RAF, Dickson ER, Beaver S, et al. Bone disease in liver transplant recipients: incidence, timing and risk factors. Transplant Proc. 23:1991;1462-1465.
4. Haagsma EB, Thijn CJP, Post JG, Slooff MJH, Gips CH. Bone disease after orthotopic liver transplantation. J Hepatol. 6:1988;94-100.
5. Hodgson SF, Dickson ER, Heinz WW, Johnson KA, Mann KG, Riggs BL. Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med. 103:1985;855-860.
6. Stellon AJ, Webb A, Compston J, Williams R. Low bone turnover state in primary biliary cirrhosis. Hepatology. 7:1987;137-142.
7. Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S. Hepatic osteodystrophy. Static and dynamic bone histomorphometry and bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology. 96:1989;213-221.
8. Diamond T, Stiel D, Lunzer M, Wilkinson M, Roche J, Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut. 31:1990;82-87.
9. Guañabens N, Parés A, Mariñoso L, Brancós MA, Piera C, Serrano S, et al. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol. 85:1990;1356-1362.
10. Rose J, Compston JE, Crawley EO, Evans W, Evans C, Smith P. Osteoporosis associated with chronic liver disease. Eur J Gastroenterol Hepatol. 3:1991;63-69.
11. McCaughan GW, Feller RB. Osteoporosis in chronic liver disease: pathogenesis, risk factors, and management. Dig Dis. 12:1994;223-231.
12. Hay JE. Bone disease in cholestatic liver disease. Gastroenterology. 108:1995;276-283.
13. Stellon AJ, Davies A, Compston J, Williams R. Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy. Gastroenterology. 89:1985;1078-1083.
14. Peris P, Parés A, Guañabens N, Pons F, de Osaba MJM, Caballería J, et al. Reduced spinal and femoral bone mass and deranged bone mineral metabolism in chronic alcoholics. Alcohol Alcohol. 27:1992;619-625.
15. Tsuneoka K, Tameda Y, Takase K, Nakano T. Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. J Gastroenterol. 31:1996;669-678.
16. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 60:1977;646.
17. Brahm H, Mallmin H, Michaelsson K, Ström H, Ljunghall S. Relationships between bone mass measurements and lifetime physical activity in a Swedish population. Calcif Tissue Int. 62:1997;400-412.
18. Briony T. Manual of Dietetic Practice, 2nd edn. 1994;Blackwell Scientific Publications, Oxford.
19. Hjorth U. Computer Intensive Statistical Methods. Validation, Model selection and bootstrap, 1st edn. 1994;Chapman and Hall, London.
20. Zetterberg C, Elmersson S, Andersson GB. Epidemiology of hip fractures in Göteborg, Sweden, 1940-1983. Clin Orthop. 191:1984;44-52.
21. Bonkovsky HL, Hawkins M, Steinberg K, Hersch T, Galambos JT, Henderson JM, et al. Prevalence and prediction of osteopenia in chronic liver disease. Hepatology. 12:1990;273-280.
22. Mitchison HC, Malcolm AJ, Bassendine MF, James OFW. Metabolic bone disease in primary biliary cirrhosis at presentation. Gastroenterology. 94:1988;463-470.
23. Eastell R, Dickson ER, Hodgson SF, Wiesner RH, Porayko MK, Wahner HW, et al. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology. 14:1991;296-300.
24. Hay JE, Lindor K, Wiesner RH, Dickson ER, Krom RAF, LaRusso NF. The metabolic bone disease of primary sclerosing cholangitis. Hepatology. 14:1991;257-261.
25. McDonald JA, Dunstan CR, Dilworth P, Sherbon K, Sheil AGR, Evans RA, et al. Bone loss after liver transplantation. Hepatology. 14:1991;613-619.
26. Arnold JC, Hauser D, Ziegler R, Kommerell B, Otto G, Theilmann L, et al. Bone disease after liver transplantation. Transplant Proc. 24:1992;2709-2710.
27. van Berkum FNR, Beukers R, Birkenhäger JC, Kooij PPM, Schalm SW, Pols HAP. Bone mass in women with primary biliary cirrhosis: the relation with histological stage and use of glucocorticoids. Gastroenterology. 99:1990;1134-1139.
28. Compston JE, Crowe JP, Wells IP, Horton LWL, Hirst D, Merrett AL, et al. Vitamin D Prophylaxis and osteomalacia in chronic cholestatic liver disease. Dig Dis. 25:1980;28-32.
29. Danielsson Å, Lorentzon R, Larsson SE. Intestinal absorption and 25-hydroxylation of vitamin D in patients with primary biliary cirrhosis. Scand J Gastroenterol. 17:1982;349-355.
30. Bengoa JM, Sitrin MD, Meredith S, Kelly SE, Shah N, Baker AL, et al. Intestinal calcium absorption and vitamin D status in chronic cholestatic liver disease. Hepatology. 4:1984;261-265.
31. Chen C-C, Wang S-S, Jeng F-S, Lee S-D. Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis? J Gastroenterol Hepatol. 11:1996;417-421.
32. Diamond T, Stiel D, Mason R, Lissner D, Bikle D, Wilson S, et al. Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease. J Clin Endocrinol Metab. 69:1989;1234-1239.
33. Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum. 28:1985;361-368.
34. Silvennoinen JA, Karttunen TJ, Niemelä SE, Manelius JJ, Lehtola J. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut. 37:1995;71-76.
35. Mitchison HC, Bassendine MF, Malcolm AJ, Watson AJ, Record CO, James OFW. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss. Hepatology. 10:1989;420-429.
36. Mitchison HC, Palmer J, Bassendine MF, Watson AJ, Record CO, James OFW. A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three year results. J Hepatol. 15:1992;336-344.
37. Olsson R, Johansson C, Lindstedt G, Mellström D. Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol. 29:1994;753-756.
38. Leuschner M, Güldütuna S, You T, Hübner K, Bhatti S, Leuschner U. Ursodeoxycholic acid and prednisolon versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. J Hepatol. 25:1996;49-57.
39. Felson DT, Zhang Y, Hannan MT, Anderson JJ. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res. 8:1993;567-572.
40. Tremollieres FA, Pouilles JM, Ribot C. Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women. J Clin Endocrinol Metab. 77:1993;683-686.
41. Michaëlsson K. Screening for osteopenia and osteoporosis-selection by body composition. Osteoporosis Int. 6:1996;120-126.
42. Merli M, Romiti A, Riggio O, Capocaccia L. Optimal nutritional indexes in chronic liver disease. J Parenter Enteral Nutr. 11:1987;130S-134S.
43. DiCecco SR, Wieners EJ, Wiesner RH, Southorn PA, Plevak DJ, Krom RAF. Assessment of nutritional status of patients with end-stage liver disease undergoing liver transplantation. Mayo Clin Proc. 64:1989;95-102.
44. Italian Multicentre Cooperative Project on nutrition in liver cirrhosis. Nutritional status in cirrhosis. J Hepatol. 21:1994;317-325.
45. Wicks C, Bray GP, Williams R. Nutritional assessment in primary biliary cirrhosis: the effect of disease severity. Clin Nutr. 14:1995;29-34.
46. Gabuzda GJ, Shear L. Metabolism of dietary protein in hepatic cirrhosis. Nutritional and clinical considerations. Am J Clin Nutr. 23:1970;479-487.